[30, 40, 41] revealed that human subjects have a significant positive correlation between circulating A‐FABP levels and metabolic syndrome characteristics, including unfavourable lipid profiles (elevated serum triglycerides and LDL‐cholesterol and reduced HDL‐cholesterol). Here, FABP4 is linked to metabolic syndrome.